Consolidated statement of comprehensive income
|
in thousand CHF |
1.1.–30.6.2023 |
1.1.–30.6.2022 (Restated) 1) |
|
Net profit |
187,330 |
83,124 |
|
|
|
|
|
Translation differences |
–49 |
–139 |
|
Items that may be reclassified subsequently to profit or loss |
–49 |
–139 |
|
|
|
|
|
Remeasurement of net defined benefit plans |
–2,149 |
–56,513 |
|
Income taxes from remeasurement of net defined benefit plans |
380 |
10,172 |
|
Share of other comprehensive income from associates and joint ventures |
–223 |
–921 |
|
Gain / (Loss) on equity instruments at fair value through other comprehensive income |
10,615 |
– |
|
Income taxes from fair value measurement on equity instruments at fair value through other comprehensive income |
–2,229 |
– |
|
Items that will not be reclassified to profit or loss |
6,394 |
–47,262 |
|
Other comprehensive income/(loss) |
6,344 |
–47,401 |
|
|
|
|
|
Comprehensive income |
193,674 |
35,723 |
|
|
|
|
|
Attributable to: |
|
|
|
– Shareholders of Galenica Ltd. |
193,343 |
35,511 |
|
– Non-controlling interests |
331 |
213 |
1) Figures restated (refer to note 4 of the Consolidated interim financial statements)
Unaudited figures